| Literature DB >> 30288396 |
L E Tellier1, J R Krieger1, A L Brimeyer1, A C Coogan1, A A Falis1, T E Rinker1, A Schudel2,3, S N Thomas1,3,4,5, C D Jarrett6,7, N J Willett1,3,7,8, E A Botchwey1,3, J S Temenoff1,3.
Abstract
To examine how the chemotactic agent stromal cell-derived factor-1alpha (SDF-1α) modulates the unique cellular milieu within rotator cuff muscle following tendon injury, we developed an injectable, heparin-based microparticle platform to locally present SDF-1α within the supraspinatus muscle following severe rotator cuff injury. SDF-1α loaded, degradable, N-desulfated heparin-based microparticles were fabricated, injected into a rat model of severe rotator cuff injury, and were retained for up to 7 days at the site. The resultant inflammatory cell and mesenchymal stem cell populations were analyzed compared to uninjured contralateral controls and, after 7 days, the fold-change in anti-inflammatory, M2-like macrophages (CD11b+CD68+CD163+, 4.3X fold-change) and mesenchymal stem cells (CD29+CD44+CD90+, 3.0X, respectively) was significantly greater in muscles treated with SDF-1α loaded microparticles than unloaded microparticles or injury alone. Our results indicate that SDF-1α loaded microparticles may be a novel approach to shift the cellular composition within the supraspinatus muscle and create a more pro-regenerative milieu, which may provide a platform to improve muscle repair following rotator cuff injury in the future.Entities:
Keywords: heparin; macrophages; mesenchymal stem cells; microparticles; stromal cell-derived factor-1α
Year: 2018 PMID: 30288396 PMCID: PMC6166879 DOI: 10.1007/s40883-018-0052-4
Source DB: PubMed Journal: Regen Eng Transl Med ISSN: 2364-4141